Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Jun;77(11):1832–1838. doi: 10.1038/bjc.1998.304

Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.

T Stokke 1, H Holte 1, L Smedshammer 1, E B Smeland 1, O Kaalhus 1, H B Steen 1
PMCID: PMC2150350  PMID: 9667654

Abstract

We have examined apoptosis and proliferation in lymph node cell suspensions from patients with B-cell non-Hodgkin's lymphoma using flow cytometry. A method was developed which allowed estimation of the fractions of apoptotic cells and cells in the S-phase of the cell cycle simultaneously with tumour-characteristic light chain expression. Analysis of the tumour S-phase fraction and the tumour apoptotic fraction in lymph node cell suspensions from 95 B-cell non-Hodgkin's lymphoma (NHL) patients revealed a non-normal distribution for both parameters. The median fraction of apoptotic tumour cells was 1.1% (25 percentiles 0.5%, 2.7%). In the same samples, the median fraction of apoptotic normal cells was higher than for the tumour cells (1.9%; 25 percentiles 0.7%, 4.0%; P = 0.03). The median fraction of tumour cells in S-phase was 1.4% (25 percentiles 0.8%, 4.8%), the median fraction of normal cells in S-phase was significantly lower than for the tumour cells (1.0%; 25 percentiles 0.6%, 1.9%; P = 0.004). When the number of cases was plotted against the logarithm of the S-phase fraction of the tumour cells, a distribution with two Gaussian peaks was needed to fit the data. One peak was centred around an S-phase fraction of 0.9%; the other was centred around 7%. These peaks were separated by a valley at approximately 3%, indicating that the S-phase fraction in NHL can be classified as 'low' (< 3%) or 'high' (> 3%), independent of the median S-phase fraction. The apoptotic fractions were log-normally distributed. The median apoptotic fraction was higher (1.5%) in the 'high' S-phase group than in the 'low' S-phase group (0.8%; P = 0.02). However, there was no significant correlation between the two parameters (P > 0.05).

Full text

PDF
1832

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aisenberg A. C., Wilkes B. M., Harris N. L. Monoclonal antibody studies in non-Hodgkin's lymphoma. Blood. 1983 Mar;61(3):469–475. [PubMed] [Google Scholar]
  2. Braylan R. C., Benson N. A., Nourse V. A. Cellular DNA of human neoplastic B-cells measured by flow cytometry. Cancer Res. 1984 Nov;44(11):5010–5016. [PubMed] [Google Scholar]
  3. Christensson B., Lindemalm C., Johansson B., Mellstedt H., Tribukait B., Biberfeld P. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma. Leuk Res. 1989;13(4):307–314. doi: 10.1016/0145-2126(89)90067-2. [DOI] [PubMed] [Google Scholar]
  4. Duque R. E., Andreeff M., Braylan R. C., Diamond L. W., Peiper S. C. Consensus review of the clinical utility of DNA flow cytometry in neoplastic hematopathology. Cytometry. 1993;14(5):492–496. doi: 10.1002/cyto.990140507. [DOI] [PubMed] [Google Scholar]
  5. Filippa D. A., Lieberman P. H., Erlandson R. A., Koziner B., Siegal F. P., Turnbull A., Zimring A., Good R. A. A study of malignant lymphomas using light and ultramicroscopic, cytochemical and immunologic technics: correlation with clinical features. Am J Med. 1978 Feb;64(2):259–268. doi: 10.1016/0002-9343(78)90054-2. [DOI] [PubMed] [Google Scholar]
  6. Gorczyca W., Bigman K., Mittelman A., Ahmed T., Gong J., Melamed M. R., Darzynkiewicz Z. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia. 1993 May;7(5):659–670. [PubMed] [Google Scholar]
  7. Hollowood K., Macartney J. C. Reduced apoptotic cell death in follicular lymphoma. J Pathol. 1991 Apr;163(4):337–342. doi: 10.1002/path.1711630411. [DOI] [PubMed] [Google Scholar]
  8. Kvaløy S., Godal T., Marton P. F., Steen H., Brenhovd I. O., Abrahamsen A. F. Spontaneous (H)-thymidine uptake in histological subgroups of human B-cell lymphomas. Scand J Haematol. 1981 Mar;26(3):221–234. doi: 10.1111/j.1600-0609.1981.tb01650.x. [DOI] [PubMed] [Google Scholar]
  9. Leech J. H., Glick A. D., Waldron J. A., Flexner J. M., Horn R. G., Collins R. D. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies. J Natl Cancer Inst. 1975 Jan;54(1):11–21. doi: 10.1093/jnci/54.1.11. [DOI] [PubMed] [Google Scholar]
  10. Leoncini L., Del Vecchio M. T., Megha T., Barbini P., Galieni P., Pileri S., Sabattini E., Gherlinzoni F., Tosi P., Kraft R. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol. 1993 Mar;142(3):755–763. [PMC free article] [PubMed] [Google Scholar]
  11. Macartney J. C., Camplejohn R. S., Morris R., Hollowood K., Clarke D., Timothy A. DNA flow cytometry of follicular non-Hodgkin's lymphoma. J Clin Pathol. 1991 Mar;44(3):215–218. doi: 10.1136/jcp.44.3.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mann R. B., Jaffe E. S., Braylan R. C., Nanba K., Frank M. M., Ziegler J. L., Berard C. W. Non-endemic Burkitts's lymphoma. A B-cell tumor related to germinal centers. N Engl J Med. 1976 Sep 23;295(13):685–691. doi: 10.1056/NEJM197609232951301. [DOI] [PubMed] [Google Scholar]
  13. Rehn S., Glimelius B., Strang P., Sundström C., Tribukait B. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma. Hematol Oncol. 1990 Jan-Feb;8(1):1–12. doi: 10.1002/hon.2900080102. [DOI] [PubMed] [Google Scholar]
  14. Stansfeld A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelényi G., Sundstrom C., Lennert K., van Unnik J. A., Mioduszewska O. Updated Kiel classification for lymphomas. Lancet. 1988 Feb 6;1(8580):292–293. doi: 10.1016/s0140-6736(88)90367-4. [DOI] [PubMed] [Google Scholar]
  15. Stokke T., Holte H., Erikstein B., Davies C. L., Funderud S., Steen H. B. Simultaneous assessment of chromatin structure, DNA content, and antigen expression by dual wavelength excitation flow cytometry. Cytometry. 1991;12(2):172–178. doi: 10.1002/cyto.990120212. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES